Home / Caspofungin / Canada
CA ATC J02AX04 · updated 2 Nov 2026
Caspofungin shortage in Canada
Is there a Caspofungin shortage in Canada?
Yes. As of 2 Nov 2026, 3 Caspofungin products are reported short in Canada. The company estimate for the return is 1 Jan 2027 (latest 30 Oct 2027). Main reason: not stated.
Also short in United States, Italy, Switzerland, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | CASPOFUNGIN FOR INJECTION (50MG) anticipated | FRESENIUS KABI CANADA LTD | 5 Nov 2026 | 30 Oct 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | CANCIDAS (10x) discontinuation | MERCK CANADA INC | not given | 1 Jan 2027 | Not stated |
| CA | CASPOFUNGIN FOR INJECTION (70 mg, 10 mL Vial) discontinuation | FRESENIUS KABI CANADA LTD | not given | 1 Mar 2027 | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.